{
  "directed": true,
  "graph": {
    "annotation_list": {
      "PPI": [
        "VirtualDocking"
      ]
    },
    "annotation_pattern": {},
    "annotation_url": {
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20190128.belanno"
    },
    "document_metadata": {
      "authors": "Yojana Gadiya",
      "contact": "yojana.gadiya@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2020 Fraunhofer Institute SCAI, All rights reserved",
      "description": "Potential Inhibitors Against 2019-nCoV Coronavirus M Protease From Clinically Approved Medicines",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "name": "PMID_32173287",
      "version": "2.0.0"
    },
    "namespace_pattern": {
      "NCBIGENE": ".*"
    },
    "namespace_url": {
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
      "DRUGBANK": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/drugbank/drugbank-20180906.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns",
      "GOBP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go-biological-process/go-biological-process-20190128.belns",
      "MESHPP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-processes/mesh-processes-20190128.belns"
    },
    "path": "32173287.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "MeSHDisease": {
          "Coronavirus Infections": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "The ~306 aa long main protease (Mpro), a key enzyme for coronavirus replication, is also encoded by the polypeptide and responsible for processing the polypeptide into functional proteins (Lai and Holmes, 2001).",
      "key": "ce70e67679e7693c4819a95c6c198a83",
      "line": 95,
      "relation": "regulates",
      "source": 21,
      "target": 12
    },
    {
      "key": "233366c36c28e38982348c6d3c1f44a0",
      "relation": "hasVariant",
      "source": 21,
      "target": 24
    },
    {
      "key": "cc8074941efc606f86614b8242ce209d",
      "relation": "hasVariant",
      "source": 21,
      "target": 22
    },
    {
      "key": "96e0d91f81dedfbc479a88122b62d366",
      "relation": "hasVariant",
      "source": 21,
      "target": 23
    },
    {
      "key": "55eadfe05eef2f8ef92f9194520a829a",
      "relation": "hasVariant",
      "source": 21,
      "target": 25
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "A previous attempt to predict drugs for the Mpro of SARS-CoV has identified two HIV-1 protease inhibitors, namely lopinavir and ritonavir, as potential candidates, both of which bind to the same target site of Mpro (Nukoolkarn et al., 2008). The conserved amino acids Thr24-Asn28 and Asn119 (numbered according to positions in SARS-CoV Mpro because the present sequence of 2019-nCoV Mpro in GenBank is in polypeptide form) formed the binding pockets for lopinavir/ritonavir in the spatial structure of both SARS-CoV Mpro and 2019-nCoV Mpro, whereas the nearby non-conserved amino acids locate far away from the binding pocket, thus would not affect its structural conservation (Fig. 1B). ",
      "key": "a4a7d98f2bcb29f50fe820520aae3fdc",
      "line": 100,
      "relation": "negativeCorrelation",
      "source": 12,
      "target": 15
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "A previous attempt to predict drugs for the Mpro of SARS-CoV has identified two HIV-1 protease inhibitors, namely lopinavir and ritonavir, as potential candidates, both of which bind to the same target site of Mpro (Nukoolkarn et al., 2008). The conserved amino acids Thr24-Asn28 and Asn119 (numbered according to positions in SARS-CoV Mpro because the present sequence of 2019-nCoV Mpro in GenBank is in polypeptide form) formed the binding pockets for lopinavir/ritonavir in the spatial structure of both SARS-CoV Mpro and 2019-nCoV Mpro, whereas the nearby non-conserved amino acids locate far away from the binding pocket, thus would not affect its structural conservation (Fig. 1B). ",
      "key": "769c6c998cbb3c3db323fd92a0305c13",
      "line": 101,
      "relation": "negativeCorrelation",
      "source": 12,
      "target": 13
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "A previous attempt to predict drugs for the Mpro of SARS-CoV has identified two HIV-1 protease inhibitors, namely lopinavir and ritonavir, as potential candidates, both of which bind to the same target site of Mpro (Nukoolkarn et al., 2008). The conserved amino acids Thr24-Asn28 and Asn119 (numbered according to positions in SARS-CoV Mpro because the present sequence of 2019-nCoV Mpro in GenBank is in polypeptide form) formed the binding pockets for lopinavir/ritonavir in the spatial structure of both SARS-CoV Mpro and 2019-nCoV Mpro, whereas the nearby non-conserved amino acids locate far away from the binding pocket, thus would not affect its structural conservation (Fig. 1B). ",
      "key": "48f5044acd47342ddb11e635ec984f5e",
      "line": 102,
      "relation": "negativeCorrelation",
      "source": 12,
      "target": 19
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "A previous attempt to predict drugs for the Mpro of SARS-CoV has identified two HIV-1 protease inhibitors, namely lopinavir and ritonavir, as potential candidates, both of which bind to the same target site of Mpro (Nukoolkarn et al., 2008). The conserved amino acids Thr24-Asn28 and Asn119 (numbered according to positions in SARS-CoV Mpro because the present sequence of 2019-nCoV Mpro in GenBank is in polypeptide form) formed the binding pockets for lopinavir/ritonavir in the spatial structure of both SARS-CoV Mpro and 2019-nCoV Mpro, whereas the nearby non-conserved amino acids locate far away from the binding pocket, thus would not affect its structural conservation (Fig. 1B). ",
      "key": "e6672cd06a1e9abadc3484975b3415d4",
      "line": 103,
      "relation": "negativeCorrelation",
      "source": 12,
      "target": 17
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "A previous attempt to predict drugs for the Mpro of SARS-CoV has identified two HIV-1 protease inhibitors, namely lopinavir and ritonavir, as potential candidates, both of which bind to the same target site of Mpro (Nukoolkarn et al., 2008). The conserved amino acids Thr24-Asn28 and Asn119 (numbered according to positions in SARS-CoV Mpro because the present sequence of 2019-nCoV Mpro in GenBank is in polypeptide form) formed the binding pockets for lopinavir/ritonavir in the spatial structure of both SARS-CoV Mpro and 2019-nCoV Mpro, whereas the nearby non-conserved amino acids locate far away from the binding pocket, thus would not affect its structural conservation (Fig. 1B). ",
      "key": "eddaf6b217081c8190302653633ec4be",
      "line": 100,
      "relation": "negativeCorrelation",
      "source": 15,
      "target": 12
    },
    {
      "key": "e01ea08ec45fe22ac86d963a2a9fa403",
      "relation": "partOf",
      "source": 6,
      "target": 15
    },
    {
      "key": "34df4f1a3ea378ae7631f6cc2c55d949",
      "relation": "partOf",
      "source": 6,
      "target": 13
    },
    {
      "key": "132032c0978f27493adf9c76af2fe1d6",
      "relation": "partOf",
      "source": 6,
      "target": 14
    },
    {
      "key": "6456d0a2c55353d0f03433aa8c683a1e",
      "relation": "partOf",
      "source": 6,
      "target": 16
    },
    {
      "key": "87fe08bc12f82263f24342122b0bc66c",
      "relation": "partOf",
      "source": 24,
      "target": 15
    },
    {
      "key": "8a0f7c5950713ad4ba4f66d76862a37b",
      "relation": "partOf",
      "source": 24,
      "target": 19
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "A previous attempt to predict drugs for the Mpro of SARS-CoV has identified two HIV-1 protease inhibitors, namely lopinavir and ritonavir, as potential candidates, both of which bind to the same target site of Mpro (Nukoolkarn et al., 2008). The conserved amino acids Thr24-Asn28 and Asn119 (numbered according to positions in SARS-CoV Mpro because the present sequence of 2019-nCoV Mpro in GenBank is in polypeptide form) formed the binding pockets for lopinavir/ritonavir in the spatial structure of both SARS-CoV Mpro and 2019-nCoV Mpro, whereas the nearby non-conserved amino acids locate far away from the binding pocket, thus would not affect its structural conservation (Fig. 1B). ",
      "key": "f419cf25cb934ab3fb16722cce1c0dcf",
      "line": 101,
      "relation": "negativeCorrelation",
      "source": 13,
      "target": 12
    },
    {
      "key": "60967c8f14750fbd897b2cf5d4adc535",
      "relation": "partOf",
      "source": 22,
      "target": 13
    },
    {
      "key": "24a9cccbed0d7c34a9ea83d6144c7c02",
      "relation": "partOf",
      "source": 22,
      "target": 17
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "A previous attempt to predict drugs for the Mpro of SARS-CoV has identified two HIV-1 protease inhibitors, namely lopinavir and ritonavir, as potential candidates, both of which bind to the same target site of Mpro (Nukoolkarn et al., 2008). The conserved amino acids Thr24-Asn28 and Asn119 (numbered according to positions in SARS-CoV Mpro because the present sequence of 2019-nCoV Mpro in GenBank is in polypeptide form) formed the binding pockets for lopinavir/ritonavir in the spatial structure of both SARS-CoV Mpro and 2019-nCoV Mpro, whereas the nearby non-conserved amino acids locate far away from the binding pocket, thus would not affect its structural conservation (Fig. 1B). ",
      "key": "3cc4bffbc2ed253889885ff7ce7e2e32",
      "line": 102,
      "relation": "negativeCorrelation",
      "source": 19,
      "target": 12
    },
    {
      "key": "ed9a1b505146eef3d38d89874c3f138a",
      "relation": "partOf",
      "source": 8,
      "target": 19
    },
    {
      "key": "d9739107de1722fab5a6450b4a8dab0a",
      "relation": "partOf",
      "source": 8,
      "target": 17
    },
    {
      "key": "9bc679dd671dba3407e84e18016c263c",
      "relation": "partOf",
      "source": 8,
      "target": 18
    },
    {
      "key": "39232a058d6e032de1b839e7da45e11e",
      "relation": "partOf",
      "source": 8,
      "target": 20
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "A previous attempt to predict drugs for the Mpro of SARS-CoV has identified two HIV-1 protease inhibitors, namely lopinavir and ritonavir, as potential candidates, both of which bind to the same target site of Mpro (Nukoolkarn et al., 2008). The conserved amino acids Thr24-Asn28 and Asn119 (numbered according to positions in SARS-CoV Mpro because the present sequence of 2019-nCoV Mpro in GenBank is in polypeptide form) formed the binding pockets for lopinavir/ritonavir in the spatial structure of both SARS-CoV Mpro and 2019-nCoV Mpro, whereas the nearby non-conserved amino acids locate far away from the binding pocket, thus would not affect its structural conservation (Fig. 1B). ",
      "key": "054cba5163a515f24a28e25d1bf66b67",
      "line": 103,
      "relation": "negativeCorrelation",
      "source": 17,
      "target": 12
    },
    {
      "key": "7a42bd3f45f8ecf4f20309835eeaf6ad",
      "relation": "partOf",
      "source": 23,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Amino acids Thr24, Thr26, and Asn119 were predicted to be the key residues for binding to the drugs (Figs. 1C and S2), forming 2 hydrogen bonds with lopinavir and 3 hydrogen bonds with ritonavir, respectively.",
      "key": "951dc8ad84976780cbcf8ac2f3d648a5",
      "line": 107,
      "relation": "increases",
      "source": 23,
      "target": 14
    },
    {
      "key": "222fa14b1f751810e14d9ffc8c3491c2",
      "relation": "partOf",
      "source": 23,
      "target": 18
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Amino acids Thr24, Thr26, and Asn119 were predicted to be the key residues for binding to the drugs (Figs. 1C and S2), forming 2 hydrogen bonds with lopinavir and 3 hydrogen bonds with ritonavir, respectively.",
      "key": "959e0a4983edf5224706b7f7043b32f5",
      "line": 108,
      "relation": "increases",
      "source": 23,
      "target": 18
    },
    {
      "key": "8b4765b8995986704007bda0b9520eae",
      "relation": "partOf",
      "source": 25,
      "target": 16
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Amino acids Thr24, Thr26, and Asn119 were predicted to be the key residues for binding to the drugs (Figs. 1C and S2), forming 2 hydrogen bonds with lopinavir and 3 hydrogen bonds with ritonavir, respectively.",
      "key": "7bb2530413e6f5654aaf954236099b06",
      "line": 109,
      "relation": "increases",
      "source": 25,
      "target": 16
    },
    {
      "key": "1387ec156d32b050269d22d0f3177c13",
      "relation": "partOf",
      "source": 25,
      "target": 20
    },
    {
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Amino acids Thr24, Thr26, and Asn119 were predicted to be the key residues for binding to the drugs (Figs. 1C and S2), forming 2 hydrogen bonds with lopinavir and 3 hydrogen bonds with ritonavir, respectively.",
      "key": "772c6b9d68886b6ca916424b9a6ec70d",
      "line": 110,
      "relation": "increases",
      "source": 25,
      "target": 20
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "9ee2cf582eecf49b362ff8a3fec27b26",
      "line": 117,
      "relation": "decreases",
      "source": 4,
      "target": 21
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "cbad6b025a4f2d81a4d1fc908b9c700e",
      "line": 118,
      "relation": "decreases",
      "source": 9,
      "target": 21
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "7fd5b02c409991b5afd51bde36101461",
      "line": 119,
      "relation": "decreases",
      "source": 5,
      "target": 21
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "17a81655469dc33103711af0c9b8c0ac",
      "line": 120,
      "relation": "decreases",
      "source": 2,
      "target": 21
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "bf333cf6c7277a9dc96317d9465c2617",
      "line": 121,
      "relation": "decreases",
      "source": 0,
      "target": 21
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "a7579087ada31a88b06451db2ad12176",
      "line": 122,
      "relation": "decreases",
      "source": 10,
      "target": 21
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "c4f85bd2d6c3125ffecb30b531597dea",
      "line": 123,
      "relation": "decreases",
      "source": 11,
      "target": 21
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "b7a7b035f40135b5cacb9affa2459f59",
      "line": 124,
      "relation": "decreases",
      "source": 1,
      "target": 21
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "51bda3975bf8ef9a5a16e72d96875e83",
      "line": 125,
      "relation": "decreases",
      "source": 3,
      "target": 21
    },
    {
      "annotations": {
        "PPI": {
          "VirtualDocking": true
        }
      },
      "citation": {
        "authors": [
          "Liu X",
          "Wang XJ"
        ],
        "date": "2020-02-13",
        "db": "PubMed",
        "db_id": "32173287",
        "db_name": "Journal of genetics and genomics = Yi chuan xue bao",
        "first": "Liu X",
        "last": "Wang XJ"
      },
      "evidence": "Based on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1; Figs. 1B and S3).",
      "key": "3185f082faa7f7648da36c924105bf2a",
      "line": 126,
      "relation": "decreases",
      "source": 7,
      "target": 21
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"4'-epidoxorubicin\")",
      "concept": {
        "name": "4'-epidoxorubicin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "aabd0f1b1a70eb741c8a462c6ab31a76"
    },
    {
      "bel": "a(CHEBI:aprepitant)",
      "concept": {
        "name": "aprepitant",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "259b19a658211dde883689ec4ca6f500"
    },
    {
      "bel": "a(CHEBI:bepotastine)",
      "concept": {
        "name": "bepotastine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "869639c4371ec17d693e0057357cf0ad"
    },
    {
      "bel": "a(CHEBI:caspofungin)",
      "concept": {
        "name": "caspofungin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "134f66068f7e23f2b67eebbf2a4f588e"
    },
    {
      "bel": "a(CHEBI:colistin)",
      "concept": {
        "name": "colistin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c1891408b905ec474db995156c7481f5"
    },
    {
      "bel": "a(CHEBI:icatibant)",
      "concept": {
        "name": "icatibant",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8ab62e356581e3e7495ee91ee8fff4bd"
    },
    {
      "bel": "a(CHEBI:lopinavir)",
      "concept": {
        "name": "lopinavir",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "540f0a29f78ff437222f25e1c2e1b0fd"
    },
    {
      "bel": "a(CHEBI:perphenazine)",
      "concept": {
        "name": "perphenazine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "fa16e8d1c35dba94f64b2d2bf41dd362"
    },
    {
      "bel": "a(CHEBI:ritonavir)",
      "concept": {
        "name": "ritonavir",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "07c1651afef7019b0cb107f1ce5fef12"
    },
    {
      "bel": "a(CHEBI:valrubicin)",
      "concept": {
        "name": "valrubicin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "6956ee895571a2b0f7e81530ec8e1130"
    },
    {
      "bel": "a(DRUGBANK:DB01240)",
      "concept": {
        "name": "DB01240",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "17a16ce7a8ba7a2fe1cfc33c120e0e11"
    },
    {
      "bel": "a(DRUGBANK:DB04894)",
      "concept": {
        "name": "DB04894",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "d85f41514e26b3b604b5f13fa688b1a9"
    },
    {
      "bel": "bp(MESHPP:\"Virus Replication\")",
      "concept": {
        "name": "Virus Replication",
        "namespace": "MESHPP"
      },
      "function": "BiologicalProcess",
      "id": "858114bf36f0f57a4194684f697eb700"
    },
    {
      "bel": "complex(a(CHEBI:lopinavir), p(ECCODE:\"3.4.22.69\", frag(\"119_119\")))",
      "function": "Complex",
      "id": "722c850df07919fe719abd4502614f18",
      "members": [
        {
          "bel": "a(CHEBI:lopinavir)",
          "concept": {
            "name": "lopinavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "540f0a29f78ff437222f25e1c2e1b0fd"
        },
        {
          "bel": "p(ECCODE:\"3.4.22.69\", frag(\"119_119\"))",
          "concept": {
            "name": "3.4.22.69",
            "namespace": "ECCODE"
          },
          "function": "Protein",
          "id": "0de78ef1910d0af273e2e37a46d81742",
          "variants": [
            {
              "kind": "frag",
              "start": 119,
              "stop": 119
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:lopinavir), p(ECCODE:\"3.4.22.69\", frag(\"24_24\")))",
      "function": "Complex",
      "id": "fdc4e2e9a74d4a9fb2adb83358fc02c0",
      "members": [
        {
          "bel": "a(CHEBI:lopinavir)",
          "concept": {
            "name": "lopinavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "540f0a29f78ff437222f25e1c2e1b0fd"
        },
        {
          "bel": "p(ECCODE:\"3.4.22.69\", frag(\"24_24\"))",
          "concept": {
            "name": "3.4.22.69",
            "namespace": "ECCODE"
          },
          "function": "Protein",
          "id": "df8110137d74b180e93601de7b8f313e",
          "variants": [
            {
              "kind": "frag",
              "start": 24,
              "stop": 24
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:lopinavir), p(ECCODE:\"3.4.22.69\", frag(\"24_28\")))",
      "function": "Complex",
      "id": "e5321f7033d664efb29e247331e67f55",
      "members": [
        {
          "bel": "a(CHEBI:lopinavir)",
          "concept": {
            "name": "lopinavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "540f0a29f78ff437222f25e1c2e1b0fd"
        },
        {
          "bel": "p(ECCODE:\"3.4.22.69\", frag(\"24_28\"))",
          "concept": {
            "name": "3.4.22.69",
            "namespace": "ECCODE"
          },
          "function": "Protein",
          "id": "67152e887f58bc3ac7656cf7edcead02",
          "variants": [
            {
              "kind": "frag",
              "start": 24,
              "stop": 28
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:lopinavir), p(ECCODE:\"3.4.22.69\", frag(\"26_26\")))",
      "function": "Complex",
      "id": "b6e1c2c17fab133c08fa69614467faa6",
      "members": [
        {
          "bel": "a(CHEBI:lopinavir)",
          "concept": {
            "name": "lopinavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "540f0a29f78ff437222f25e1c2e1b0fd"
        },
        {
          "bel": "p(ECCODE:\"3.4.22.69\", frag(\"26_26\"))",
          "concept": {
            "name": "3.4.22.69",
            "namespace": "ECCODE"
          },
          "function": "Protein",
          "id": "b0c0dfa4dd814cbb8afa8680989eef25",
          "variants": [
            {
              "kind": "frag",
              "start": 26,
              "stop": 26
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:ritonavir), p(ECCODE:\"3.4.22.69\", frag(\"119_119\")))",
      "function": "Complex",
      "id": "b9731ae0ca0e271f5daf2428a18ddb8a",
      "members": [
        {
          "bel": "a(CHEBI:ritonavir)",
          "concept": {
            "name": "ritonavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "07c1651afef7019b0cb107f1ce5fef12"
        },
        {
          "bel": "p(ECCODE:\"3.4.22.69\", frag(\"119_119\"))",
          "concept": {
            "name": "3.4.22.69",
            "namespace": "ECCODE"
          },
          "function": "Protein",
          "id": "0de78ef1910d0af273e2e37a46d81742",
          "variants": [
            {
              "kind": "frag",
              "start": 119,
              "stop": 119
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:ritonavir), p(ECCODE:\"3.4.22.69\", frag(\"24_24\")))",
      "function": "Complex",
      "id": "fab52b6ea0621efe63b1faa12fa15c00",
      "members": [
        {
          "bel": "a(CHEBI:ritonavir)",
          "concept": {
            "name": "ritonavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "07c1651afef7019b0cb107f1ce5fef12"
        },
        {
          "bel": "p(ECCODE:\"3.4.22.69\", frag(\"24_24\"))",
          "concept": {
            "name": "3.4.22.69",
            "namespace": "ECCODE"
          },
          "function": "Protein",
          "id": "df8110137d74b180e93601de7b8f313e",
          "variants": [
            {
              "kind": "frag",
              "start": 24,
              "stop": 24
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:ritonavir), p(ECCODE:\"3.4.22.69\", frag(\"24_28\")))",
      "function": "Complex",
      "id": "59ecf64e2dab16bfa7c8238c647e3d4f",
      "members": [
        {
          "bel": "a(CHEBI:ritonavir)",
          "concept": {
            "name": "ritonavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "07c1651afef7019b0cb107f1ce5fef12"
        },
        {
          "bel": "p(ECCODE:\"3.4.22.69\", frag(\"24_28\"))",
          "concept": {
            "name": "3.4.22.69",
            "namespace": "ECCODE"
          },
          "function": "Protein",
          "id": "67152e887f58bc3ac7656cf7edcead02",
          "variants": [
            {
              "kind": "frag",
              "start": 24,
              "stop": 28
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:ritonavir), p(ECCODE:\"3.4.22.69\", frag(\"26_26\")))",
      "function": "Complex",
      "id": "d6533eb9ba9513096be1535c8aed85df",
      "members": [
        {
          "bel": "a(CHEBI:ritonavir)",
          "concept": {
            "name": "ritonavir",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "07c1651afef7019b0cb107f1ce5fef12"
        },
        {
          "bel": "p(ECCODE:\"3.4.22.69\", frag(\"26_26\"))",
          "concept": {
            "name": "3.4.22.69",
            "namespace": "ECCODE"
          },
          "function": "Protein",
          "id": "b0c0dfa4dd814cbb8afa8680989eef25",
          "variants": [
            {
              "kind": "frag",
              "start": 26,
              "stop": 26
            }
          ]
        }
      ]
    },
    {
      "bel": "p(ECCODE:\"3.4.22.69\")",
      "concept": {
        "name": "3.4.22.69",
        "namespace": "ECCODE"
      },
      "function": "Protein",
      "id": "81569d1965f33bb435a6c8e4e11dd2a5"
    },
    {
      "bel": "p(ECCODE:\"3.4.22.69\", frag(\"119_119\"))",
      "concept": {
        "name": "3.4.22.69",
        "namespace": "ECCODE"
      },
      "function": "Protein",
      "id": "0de78ef1910d0af273e2e37a46d81742",
      "variants": [
        {
          "kind": "frag",
          "start": 119,
          "stop": 119
        }
      ]
    },
    {
      "bel": "p(ECCODE:\"3.4.22.69\", frag(\"24_24\"))",
      "concept": {
        "name": "3.4.22.69",
        "namespace": "ECCODE"
      },
      "function": "Protein",
      "id": "df8110137d74b180e93601de7b8f313e",
      "variants": [
        {
          "kind": "frag",
          "start": 24,
          "stop": 24
        }
      ]
    },
    {
      "bel": "p(ECCODE:\"3.4.22.69\", frag(\"24_28\"))",
      "concept": {
        "name": "3.4.22.69",
        "namespace": "ECCODE"
      },
      "function": "Protein",
      "id": "67152e887f58bc3ac7656cf7edcead02",
      "variants": [
        {
          "kind": "frag",
          "start": 24,
          "stop": 28
        }
      ]
    },
    {
      "bel": "p(ECCODE:\"3.4.22.69\", frag(\"26_26\"))",
      "concept": {
        "name": "3.4.22.69",
        "namespace": "ECCODE"
      },
      "function": "Protein",
      "id": "b0c0dfa4dd814cbb8afa8680989eef25",
      "variants": [
        {
          "kind": "frag",
          "start": 26,
          "stop": 26
        }
      ]
    }
  ]
}